- Home
- XNCR vs GDRX Comparison
XNCR vs GDRX Comparison
Compare XNCR & GDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XNCR | GDRX |
|---|---|---|
| Founded | 1997 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 881.9M | 868.9M |
| IPO Year | 2013 | 2020 |
Fundamental Metrics
Financial Performance| Metric | XNCR | GDRX |
|---|---|---|
| Price | $13.52 | $2.00 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 10 |
| Target Price | ★ $22.78 | $4.78 |
| AVG Volume (30 Days) | 429.4K | ★ 3.2M |
| Earning Date | 05-22-2026 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 65.36 | ★ 125.00 |
| EPS | N/A | ★ 0.09 |
| Revenue | $125,576,000.00 | ★ $796,853,000.00 |
| Revenue This Year | $18.68 | $2.35 |
| Revenue Next Year | N/A | $2.53 |
| P/E Ratio | ★ N/A | $35.00 |
| Revenue Growth | ★ 13.65 | 0.57 |
| 52 Week Low | $6.92 | $2.10 |
| 52 Week High | $18.69 | $5.61 |
Technical Indicators
Market Signals| Indicator | XNCR | GDRX |
|---|---|---|
| Relative Strength Index (RSI) | 60.87 | 37.08 |
| Support Level | $12.57 | N/A |
| Resistance Level | $15.59 | $2.87 |
| Average True Range (ATR) | 0.83 | 0.16 |
| MACD | 0.24 | 0.01 |
| Stochastic Oscillator | 70.96 | 13.17 |
Price Performance
Historical ComparisonAbout XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
About GDRX GoodRx Holdings Inc.
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.